The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide
BONE MARROW TRANSPLANTATION(2016)
摘要
The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide
更多查看译文
关键词
cmv,cyclophosphamide,clinical outcome,serological status,t-cell,haplo-hsct,post-transplant
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要